Aperio Group’s Akcea Therapeutics Inc AKCA Stock Holding History

Aperio Group’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-17,934	Closed	-$325K	–	2470
2020 Q3	$325K	Buy	17,934 +7,046	+65%	+$100K	﹤0.01%	2037
2020 Q2	$149K	Buy	+10,888	New	+$168K	﹤0.01%	2232
2019 Q3	–	Sell	-37	Closed	-$1K	–	2960
2019 Q2	$1K	Buy	+37	New	+$914	﹤0.01%	3008

Aperio Group's AKCA Position: Q4 2020 in Review

Aperio Group sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 17,934 shares — an estimated $325K sold.

Aperio Group first reported a position in AKCA in Q2 2019 and held it in 3 quarters. The position peaked at $325K in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

Aperio Group reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
Aperio Group sold 17,934 Akcea Therapeutics Inc shares in Q4 2020, an estimated $325K.
Aperio Group first reported a position in Akcea Therapeutics Inc in Q2 2019 and held it in 3 quarters.
Aperio Group's Akcea Therapeutics Inc position peaked at $325K in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.